COVID-19 & Inhaled Corticosteroids: Can They Be Used as a Possible T…

Dan Nicolau

Lysis for Pulmonary Embolism

Michael Jolly

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

CHEST 2021: Patient With Intermediate Risk-PE Should Go for Thrombol…

CHEST 2021 Coverage

B. Dalal

The Use of Donor Organ From Donors With a History of COVID-19 or Wit…

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

R. Patrick Wood

Percutaneous Thromboaspiration and Thrombolysis in Massive PE

Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

O. Ajuluchukwu

Role of Thrombolysis for Patients With Acute Intermediate-Risk Pulmo…

CHEST 2022 Coverage

B. Dalal

COVID-19 & Prevalence of Asthma: Are Inhaled Corticosteroids Protect…

Temple Lung Center

G. Fernandez Romero

It’s Time to Switch to Tenecteplase

Houston Methodist

A. Khalafallah

Q&A: Thrombus Management

ARCH Advanced Revascularization Symposium

K. Rosenfield, S. Mathews, A. G. El-Shafei

Thrombolysis/Thrombectomy in Acute DVT and PE: Does CDT Reduce PA Pr…

American Heart & Vascular Institute

N. Sunkara

Recanalization Therapies of Acute Ischemic Stroke in the Very Elderl…

World Stroke Organization

J. Korv

Thrombolysis—Is it Treatment of Choice for Massive PE?

PERT Consortium 2018

Risk of Infections, Cancer, Heart Disease, and Blood Clots in Alopec…

Evidence-Based Hair

J. Donovan

PE Interventions: Patient and Device Selection

University of Miami

S. Afanador

ERS 2023 Insights: Different Thrombus Recanalization Strategies in P…

ERS 2023 Insights

D. Jimenez

Benefits of Stroke Treatment on a Mobile Stroke Unit Compared to Sta…

James Grotta

Pulmonary Embolectomy: Interventional Therapies for Pulmonary Emboli…

The 10th Annual Western New England Acute Cardiology Conference

A. Singh